Oxtellar XR 300 MG tablet 100S
Ended Awarded Last action
- Contract number
- SPE2DR26FXR4P
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,241
Award facts
- Contract value 100% obligated
- $10,241.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 16, 2026, the Defense Logistics Agency awarded a delivery order valued at $10,241.04 to AmerisourceBergen Drug Corp for the supply of Oxtellar XR 300 mg tablets (100 count). This firm fixed-price, non-set-aside contract is scheduled for completion by January 20, 2026, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive $999.999 billion global pharmaceutical support vehicle that enables the company to deliver a broad range of prescription medications, generic drugs, vaccines, and medical supplies to support military healthcare programs worldwide through December 2026.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving Defense Health Agency and other military healthcare systems. The company's federal contract portfolio demonstrates extensive experience fulfilling competitively awarded delivery orders for specialized pharmaceutical products across multiple therapeutic domains, positioning it as a significant supplier within the military medical supply chain. This specific delivery order for Oxtellar XR, a medication used in neurological treatment, exemplifies the company's role in ensuring pharmaceutical availability for federal healthcare beneficiaries.
Quick answers
Who was awarded contract SPE2DR26FXR4P?
SPE2DR26FXR4P was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26FXR4P worth?
The government has obligated $10,241 on SPE2DR26FXR4P.
Is contract SPE2DR26FXR4P an order under another contract?
Yes. SPE2DR26FXR4P is a delivery order under SPE2DR25D6029, an indefinite delivery contract.
Was contract SPE2DR26FXR4P competed?
The extent of competition for SPE2DR26FXR4P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award